Eric Devroe
Director de Operaciones en ACRIVON THERAPEUTICS, INC. .
Fortuna: 585 252 $ al 30/04/2024
Perfil
Eric J.
Devroe was the founder of Opsonix, Inc. (founded in 2015) where he served as the Chief Executive Officer & Director from 2015 to 2018.
Dr. Devroe is also the founder of Xione Therapeutics, Inc...
Dr. Devroe's current job is as the Chief Operating Officer at Acrivon Therapeutics, Inc. since 2022.
Dr. Devroe's former jobs include working as a Scientist at Asuragen, Inc., as a Principal at Codon Devices, Inc., and as the VP-Business & Strategy Development at Metamark Genetics, Inc. Dr. Devroe's education includes a doctorate degree from Harvard University and an undergraduate degree from The University of Texas at Austin.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 17/05/2024 | 69 097 ( 0.22% ) | 585 252 $ | 30/04/2024 |
Cargos activos de Eric Devroe
| Empresas | Cargo | Inicio |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Director de Operaciones | 01/08/2022 |
Antiguos cargos conocidos de Eric Devroe.
| Empresas | Cargo | Fin |
|---|---|---|
Opsonix, Inc.
 Opsonix, Inc. Medical SpecialtiesHealth Technology Opsonix, Inc. manufactures and distributes medical devices. It commercializes and develops products to transform the treatment and diagnosis of sepsis. The company was founded on April 11, 2014 and is headquartered in Cambridge, MA. | Fundador | 01/01/2018 |
Xione Therapeutics, Inc.
 Xione Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xione Therapeutics, Inc. engages in the provision of biotechnology services. The company is headquartered in Houston, TX. | Director Ejecutivo | - |
Codon Devices, Inc.
 Codon Devices, Inc. Pharmaceuticals: MajorHealth Technology Codon Devices, Inc. produces pharmaceuticals and biorefineries for the production of industrial chemicals and bio-energy. The firm designs and constructs biological components such as enzymes, biopharmaceuticals, and cell lines for improved function. Its customers include the biotechnology, pharmaceutical, and agriculture sectors. The company was founded by Noubar B. Afeyan, George Church, Drew Endy, Joseph M. Jacobson and Jay Keasling in 2004 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Asuragen, Inc.
 Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Corporate Officer/Principal | - |
Metamark Genetics, Inc.
 Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Director de Operaciones | 23/03/2011 |
Formación de Eric Devroe.
| Harvard University | Doctorate Degree |
| The University of Texas at Austin | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ACRIVON THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Health Technology |
Codon Devices, Inc.
Codon Devices, Inc. Pharmaceuticals: MajorHealth Technology Codon Devices, Inc. produces pharmaceuticals and biorefineries for the production of industrial chemicals and bio-energy. The firm designs and constructs biological components such as enzymes, biopharmaceuticals, and cell lines for improved function. Its customers include the biotechnology, pharmaceutical, and agriculture sectors. The company was founded by Noubar B. Afeyan, George Church, Drew Endy, Joseph M. Jacobson and Jay Keasling in 2004 and is headquartered in Cambridge, MA. | Health Technology |
Metamark Genetics, Inc.
Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Health Services |
Opsonix, Inc.
Opsonix, Inc. Medical SpecialtiesHealth Technology Opsonix, Inc. manufactures and distributes medical devices. It commercializes and develops products to transform the treatment and diagnosis of sepsis. The company was founded on April 11, 2014 and is headquartered in Cambridge, MA. | Health Technology |
Xione Therapeutics, Inc.
Xione Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xione Therapeutics, Inc. engages in the provision of biotechnology services. The company is headquartered in Houston, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Eric Devroe